Related Experiment Video
Updated: Sep 15, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Present and future treatment of pancreatic cancer
1Department of Hematology/Oncology, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Munich, Germany.
Abstract:
Gemcitabine has become a new standard for treatment of advanced pancreatic cancer. This development is based not only on drug efficacy but also on a favorable side-effect profile. Combinations of gemcitabine with antitumor drugs such as cisplatin, 5-fluorouracil, docetaxel, irinotecan, oxaliplatin, or capecitabine, and biological agents such as cetuximab or trastuzumab, have yielded promising results in phase II trials. However, none of these combinations has yet reached the level of an evidence-based standard treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:

